AR and hydrops fetalis: We and others have shown that in addition to the endogenous β1-AR ligand norepinephrine (NE), autoantibodies against β1-AR (β1-AA), harboring agonist-like effects, circulate in the sera of 30–40% of HF patients [2, 3].